Sign inJoin waitlistJoin the waitlist

Michael Cavnar

Promotion to Associate Professor with Tenure · University of Kentucky College of Medicine

Credentials: · · · · ·

History

University of Kentucky College of Medicine
Present
University of Kentucky College of Medicine
Present
North Fork Valley Community Health Center
Present

Complex General Surgical Oncology
Memorial Sloan Kettering Cancer Center
2014–2016
New York University Medical Center
2007–2014
Columbia Univ Coll of Phys & Surgeons
2003–2007

Research

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
Nature Medicine · 2011 · 446 citations
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
The Journal of Experimental Medicine · 2013 · First of 16 authors · 115 citations
Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis
Journal of Leukocyte Biology · 2011 · 73 citations

Ronald DeMatteo
18 papers
Joseph Kim
17 papers
Reema Patel
15 papers
Prakash Pandalai
14 papers
Vinod Balachandran
10 papers · 4 as a fellow
HM
Hannah Mcdonald
9 papers · 4 as a resident
Jill Kolesar
9 papers
CA
Cristina Antonescu
8 papers
MH
Megan Harper
8 papers · 1 as a resident
ML
Miranda Lin
7 papers · 2 as a resident
SG
Sepideh Gholami
7 papers · 1 as a fellow
Mautin Barry-Hundeyin
6 papers

Clinical trials

Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Principal investigator · Recruiting · Phase 2
Michael J Cavnar, MD
2026–2030
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma
Principal investigator · Terminated
Michael J Cavnar, MD
2020–2022
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2025–2027
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2023–2034